Harms et al. investigated CD161bright CD8+ T cells in patients with juvenile T1D whose clinical onset was within 12 months and demonstrated there was no reduction of these cells in the peripheral blood of patients (76). This evidence concerns the gene CD8A and type 1 diabetes mellitus.